UNSPSC 51241514: Carboxymethylcellulose/glycerin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP500. This VA Drug Class (OP500) classifies this compound as belonging to the group EYE WASHES/LUBRICANTS.

UNSPSC 51241514 Carboxymethylcellulose/glycerin is a Commodity code that encompasses active pharmaceutical ingredients and excipients used in generic and over-the-counter drug formulations. State and local governments procure these materials primarily through multistate cooperative purchasing alliances that aggregate demand across health and human services agencies, correctional facilities, and other public health entities. The work involves qualifying manufacturers as suppliers of pharmaceutical-grade raw materials and finished goods, with vendors required to maintain FDA compliance, current Good Manufacturing Practices (cGMP) certification, and Drug Supply Chain Security Act (DSCSA) compliance. Issuing bodies are predominantly state cooperative purchasing offices administering multistate procurement vehicles; individual state health departments and agencies rarely issue standalone solicitations for these materials, instead leveraging cooperative agreements negotiated by lead states on behalf of member jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products serving participating state and local government facilities across Minnesota, Oregon, and other member states. Vendors must distribute through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and demonstrate pricing flexibility across flat-price, net-price, and WAC-minus structures. Proposals are weighted heavily on price competitiveness (75 percent), with secondary emphasis on fixed pricing, EDI capability, administrative-fee compliance, and format adherence. The contract term is two years for new responders, with optional extensions through June 30, 2028 for incumbents. All products must be available by May 15, 2026, when awarded vendors will be communicated to wholesalers, with resulting agreements effective July 1, 2026.